These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1548521)

  • 1. Curability of solitary bone plasmacytoma.
    Dimopoulos MA; Goldstein J; Fuller L; Delasalle K; Alexanian R
    J Clin Oncol; 1992 Apr; 10(4):587-90. PubMed ID: 1548521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy in the treatment of solitary plasmacytoma.
    Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
    Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.
    Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1063-7. PubMed ID: 9719116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcome in solitary bone plasmacytomata with combined therapy.
    Avilés A; Huerta-Guzmán J; Delgado S; Fernández A; Díaz-Maqueo JC
    Hematol Oncol; 1996 Sep; 14(3):111-7. PubMed ID: 9119355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitary plasmacytoma.
    Dagan R; Morris CG; Kirwan J; Mendenhall WM
    Am J Clin Oncol; 2009 Dec; 32(6):612-7. PubMed ID: 19593082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy of solitary plasmacytoma.
    Krause S; Hillengass J; Goldschmidt H; Debus J; Neuhof D
    Ann Hematol; 2011 Sep; 90(9):1093-7. PubMed ID: 21336625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years.
    Barzenje DA; Kolstad A; Ghanima W; Holte H
    Hematol Oncol; 2018 Feb; 36(1):217-223. PubMed ID: 28393375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.
    Suh YG; Suh CO; Kim JS; Kim SJ; Pyun HO; Cho J
    Ann Hematol; 2012 Nov; 91(11):1785-93. PubMed ID: 22752147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.
    Wilder RB; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
    Cancer; 2002 Mar; 94(5):1532-7. PubMed ID: 11920511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solitary plasmacytoma of bone and soft tissue.
    Bolek TW; Marcus RB; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):329-33. PubMed ID: 8892456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of solitary extramedullary plasmacytoma.
    Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
    Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solitary plasmacytoma of bone: treatment, progression, and survival.
    Chak LY; Cox RS; Bostwick DG; Hoppe RT
    J Clin Oncol; 1987 Nov; 5(11):1811-5. PubMed ID: 3681369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary plasmacytoma of bone and asymptomatic multiple myeloma.
    Dimopoulos MA; Moulopoulos A; Delasalle K; Alexanian R
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):359-69. PubMed ID: 1582978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy in the management of solitary extramedullary plasmacytoma.
    Chao MW; Gibbs P; Wirth A; Quong G; Guiney MJ; Liew KH
    Intern Med J; 2005 Apr; 35(4):211-5. PubMed ID: 15836498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmacytoma. Treatment results and conversion to myeloma.
    Holland J; Trenkner DA; Wasserman TH; Fineberg B
    Cancer; 1992 Mar; 69(6):1513-7. PubMed ID: 1540888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solitary bone and extramedullary plasmacytoma.
    Weber DM
    Hematology Am Soc Hematol Educ Program; 2005; ():373-6. PubMed ID: 16304406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary plasmacytoma: experiences from Central Anatolia.
    Coskun HS; Er O; Soyuer S; Altinbas M; Eser B; Karahacioglu E; Altuntas F
    Ir J Med Sci; 2005; 174(1):33-6. PubMed ID: 15868887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.
    Tsang RW; Campbell BA; Goda JS; Kelsey CR; Kirova YM; Parikh RR; Ng AK; Ricardi U; Suh CO; Mauch PM; Specht L; Yahalom J
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):794-808. PubMed ID: 29976492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
    Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
    Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.
    Kilciksiz S; Karakoyun-Celik O; Agaoglu FY; Haydaroglu A
    ScientificWorldJournal; 2012; 2012():895765. PubMed ID: 22654647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.